Dietary components as epigenetic-regulating agents against cancer

被引:49
作者
Chang, Ling-Chu [1 ]
Yu, Yung-Luen [2 ,3 ,4 ]
机构
[1] China Med Univ Hosp, Chinese Med Res & Dev Ctr, Taichung 404, Taiwan
[2] China Med Univ, Grad Inst Canc Biol, Taichung 404, Taiwan
[3] China Med Univ Hosp, Ctr Mol Med, Taichung 404, Taiwan
[4] Asia Univ, Dept Biotechnol, Taichung 413, Taiwan
来源
BIOMEDICINE-TAIWAN | 2016年 / 6卷 / 01期
关键词
Dietary component; Epigenetic modification; Cancer;
D O I
10.7603/s40681-016-0002-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Carcinogenesis is a complicated process that involves the deregulation of epigenetics resulting in cellular transformational events, such proliferation, differentiation, and metastasis. Epigenetic machinery changes the accessibility of chromatin to transcriptional regulation through DNA modification. The collaboration of epigenetics and gene transcriptional regulation creates a suitable microenvironment for cancer development, which is proved by the alternation in cell proliferation, differentiation, division, metabolism, DNA repair and movement. Therefore, the reverse of epigenetic dysfunction may provide a possible strategy and new therapeutic targets for cancer treatment. Many dietary components such as sulforaphane and epigallocate-chin-3-gallate have been demonstrated to exert chemopreventive influences, such as reducing tumor growth and enhancing cancer cell death. Anticancer mechanistic studies also indicated that dietary components could display the ability to reverse epigenetic deregulation in assorted tumors via reverting the adverse epigenetic regulation, including alternation of DNA methylation and histone modification, and modulation of microRNA expression. Therefore, dietary components as therapeutic agents on epigenetics becomes an attractive approach for cancer prevention and intervention at the moment. In this review, we summarize the recent discoveries and underlying mechanisms of the most common dietary components for cancer prevention via epigenetic regulation.
引用
收藏
页码:9 / 16
页数:8
相关论文
共 98 条
[1]   Bioavailability of curcumin: Problems and promises [J].
Anand, Preetha ;
Kunnumakkara, Ajaikumar B. ;
Newman, Robert A. ;
Aggarwal, Bharat B. .
MOLECULAR PHARMACEUTICS, 2007, 4 (06) :807-818
[2]   Sulforaphane Suppresses Polycomb Group Protein Level via a Proteasome-Dependent Mechanism in Skin Cancer Cells [J].
Balasubramanian, Sivaprakasam ;
Chew, Yap Ching ;
Eckert, Richard L. .
MOLECULAR PHARMACOLOGY, 2011, 80 (05) :870-878
[3]   Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription [J].
Balasubramanyam, K ;
Varier, RA ;
Altaf, M ;
Swaminathan, V ;
Siddappa, NB ;
Ranga, U ;
Kundu, TK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (49) :51163-51171
[4]   Multi-targeted therapy of cancer by genistein [J].
Banerjee, Sanjeev ;
Li, Yiwei ;
Wang, Zhiwei ;
Sarkar, Fazlul H. .
CANCER LETTERS, 2008, 269 (02) :226-242
[5]   Reversing histone methylation [J].
Bannister, AJ ;
Kouzarides, T .
NATURE, 2005, 436 (7054) :1103-1106
[6]   Cell Signaling and Transcriptional Regulation via Histone Phosphorylation [J].
Berger, S. L. .
NUCLEAR ORGANIZATION AND FUNCTION, 2010, 75 :23-26
[7]   The mammalian epigenome [J].
Bernstein, Bradley E. ;
Meissner, Alexander ;
Lander, Eric S. .
CELL, 2007, 128 (04) :669-681
[8]   CPG-RICH ISLANDS AND THE FUNCTION OF DNA METHYLATION [J].
BIRD, AP .
NATURE, 1986, 321 (6067) :209-213
[10]   SirT1-null mice develop tumors at normal rates but are poorly protected by resveratrol [J].
Boily, G. ;
He, X. H. ;
Pearce, B. ;
Jardine, K. ;
McBurney, M. W. .
ONCOGENE, 2009, 28 (32) :2882-2893